COVID-19: Caring for Patients and Communities
Vaccination against COVID-19 appears to lower the risk of long COVID, according to a growing body of research.
Adults who received an initial Johnson & Johnson (J&J) COVID-19 vaccine should receive a Pfizer or Moderna booster at least two months later for the best protection
In a cohort study of 112,269 U.S. adult patients with moderate COVID-19, aspirin use during the first day of hospitalization was associated with lower 28-day in-hospital mortality
The omicron subvariant BA.2 accounts for 35% of U.S. COVID-19 cases nationwide and more than 50% in the Northeast, according to estimates from the CDC
Data released by the Centers for Disease Control and Prevention (CDC) indicate COVID-19 booster shots were instrumental in reducing hospitalizations in January 2022.
Philips Respironics has recalled certain V60 and V60 Plus ventilators due to an expired adhesive, the Food and Drug Administration (FDA) announced this week.
America’s Blood Centers posted a bulletin this month, alerting hospitals to ways they can help address the nation’s blood shortage.
According to the Centers for Disease Control and Prevention, the omicron BA.2 subvariant of omicron accounted for roughly 23% of the coronavirus variants
Peak rates of COVID-19 hospitalization among U.S. infants and children under age 5 were roughly five times higher
As trained problem solvers, nurses and engineers have much in common, according to the first in a series of articles on nurse innovators